Tower Research Capital LLC (TRC) - RXI PHARMACEUTICALS CORP NEW ownership

Back to all holdings Add to watchlist

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 25 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q4 2015$0
-100.0%
162
-95.0%
0.00%–
Q4 2014$5,0000.0%3,246
+94.6%
0.00%
-100.0%
Q2 2014$5,000
-72.2%
1,668
-61.5%
0.00%
-50.0%
Q1 2014$18,000–4,327–0.00%–
 Download
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q1 2016.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders